The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer’s disease

被引:0
|
作者
Hlin Kvartsberg
Tammaryn Lashley
Christina E. Murray
Gunnar Brinkmalm
Nicholas C. Cullen
Kina Höglund
Henrik Zetterberg
Kaj Blennow
Erik Portelius
机构
[1] The Sahlgrenska Academy at the University of Gothenburg,Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology
[2] Sahlgrenska University Hospital/Mölndal,Queen Square Brain Bank for Neurological Disorders, Department of Movement Disorders
[3] UCL Institute of Neurology,Department of Neurodegenerative Disease
[4] UCL Institute of Neurology,Clinical Neurochemistry Laboratory
[5] UK Dementia Research Institute at UCL,Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Disease Research, Neurogeriatrics Division
[6] Sahlgrenska University Hospital,undefined
[7] Karolinska Institutet,undefined
来源
Acta Neuropathologica | 2019年 / 137卷
关键词
Neurogranin; Alzheimer’s disease; Brain tissue; Familial Alzheimer’s disease; Mass spectrometry;
D O I
暂无
中图分类号
学科分类号
摘要
Synaptic degeneration and neuronal loss are early events in Alzheimer’s disease (AD), occurring long before symptom onset, thus making synaptic biomarkers relevant for enabling early diagnosis. The postsynaptic protein neurogranin (Ng) is a cerebrospinal fluid (CSF) biomarker for AD, also in the prodromal phase. Here we tested the hypothesis that during AD neurodegeneration, processing of full-length Ng into endogenous peptides in the brain is increased. We characterized Ng in post-mortem brain tissue and investigated the levels of endogenous Ng peptides in relation to full-length protein in brain tissue of patients with sporadic (sAD) and familial Alzheimer’s disease (fAD), healthy controls and individuals who were cognitively unaffected but amyloid-positive (CU-AP) in two different brain regions. Brain tissue from parietal cortex [sAD (n = 10) and age-matched controls (n = 10)] and temporal cortex [sAD (n = 9), fAD (n = 10), CU-AP (n = 13) and controls (n = 9)] were included and all the samples were analyzed by three different methods. Using high-resolution mass spectrometry, 39 endogenous Ng peptides were identified while full-length Ng was found to be modified including disulfide bridges or glutathione. In sAD parietal cortex, the ratio of peptide-to-total full-length Ng was significantly increased for eight endogenous Ng peptides compared to controls. In the temporal cortex, several of the peptide-to-total full-length Ng ratios were increased in both sAD and fAD cases compared to controls and CU-AP. This finding was confirmed by western blot, which mainly detects full-length Ng, and enzyme-linked immunosorbent assay, most likely detecting a mix of peptides and full-length Ng. In addition, Ng was significantly associated with the degree of amyloid and tau pathology. These results suggest that processing of Ng into peptides is increased in AD brain tissue, which may reflect the ongoing synaptic degeneration, and which is also mirrored as increased levels of Ng peptides in CSF.
引用
收藏
页码:89 / 102
页数:13
相关论文
共 50 条
  • [11] Amyloid beta protein in plasma from patients with sporadic Alzheimer's disease
    Tamaoka, A
    Fukushima, T
    Sawamura, N
    Ishikawa, K
    Oguni, E
    Komatsuzaki, Y
    Shoji, S
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1996, 141 (1-2) : 65 - 68
  • [12] Cell cycle regulation distinguishes lymphocytes from sporadic and familial Alzheimer's disease patients
    Bialopiotrowicz, Emilia
    Kuzniewska, Bozena
    Kachamakova-Trojanowska, Neli
    Barcikowska, Maria
    Kuznicki, Jacek
    Wojda, Urszula
    NEUROBIOLOGY OF AGING, 2011, 32 (12) : 2319.e13 - 2319.e26
  • [13] LR11/SorLA expression is reduced in sporadic Alzheimer disease but not in familial Alzheimer disease
    Dodson, Sara E.
    Gearing, Marla
    Lippa, Carol F.
    Montine, Thomas J.
    Levey, Allan I.
    Lah, James J.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2006, 65 (09): : 866 - 872
  • [14] Familial and sporadic Alzheimer's disease: a cognitive comparison
    Buttari, F.
    Gasparini, M.
    Talarico, G.
    Canevelli, M.
    Salati, E.
    Tosto, G.
    Piacentini, E.
    Lenzi, G. L.
    Bruno, G.
    JOURNAL OF NEUROLOGY, 2007, 254 : 150 - 150
  • [15] BRAIN GLUCOSE TRANSPORTER PROTEIN 2 AND SPORADIC ALZHEIMER'S DISEASE
    Salkovic-Petrisic, Melita
    Riederer, Peter
    TRANSLATIONAL NEUROSCIENCE, 2010, 1 (03) : 200 - 206
  • [16] Nicastrin gene in familial and sporadic Alzheimer's disease
    Confaloni, A
    Terreni, L
    Piscopo, P
    Crestini, A
    Campeggia, LM
    Frigerio, CS
    Blotta, I
    Perri, M
    Di Natale, M
    Maletta, R
    Marcon, G
    Franceschi, M
    Bruni, AC
    Forloni, G
    Cantafora, A
    NEUROSCIENCE LETTERS, 2003, 353 (01) : 61 - 65
  • [17] Clinical features of sporadic and familial Alzheimer's disease
    Rossor, MN
    Fox, NC
    Freeborough, PA
    Harvey, RJ
    NEURODEGENERATION, 1996, 5 (04): : 393 - 397
  • [18] Molecular Basis of Familial and Sporadic Alzheimer's Disease
    Dorszewska, Jolanta
    Prendecki, Michal
    Oczkowska, Anna
    Dezor, Mateusz
    Kozubski, Wojciech
    CURRENT ALZHEIMER RESEARCH, 2016, 13 (09) : 952 - 963
  • [19] Brain Expression of Presenilins in Sporadic and Early-onset, Familial Alzheimer’s Disease
    Paul M. Mathews
    Anne M. Cataldo
    Benjamin H. Kao
    Anna G. Rudnicki
    Xi Qin
    John L. Yang
    Ying Jiang
    Melanie Picciano
    Christine Hulette
    Carol F. Lippa
    Thomas D. Bird
    David Nochlin
    Jochen Walter
    Christian Haass
    Lyne Lévesque
    Paul E. Fraser
    Athena Andreadis
    Ralph A. Nixon
    Molecular Medicine, 2000, 6 : 878 - 891
  • [20] Brain expression of presenilins in sporadic and early-onset, familial Alzheimer's disease
    Mathews, PM
    Cataldo, AM
    Kao, BH
    Rudnicki, AG
    Qin, X
    Yang, JL
    Jiang, Y
    Picciano, M
    Hulette, C
    Lippa, CF
    Bird, TD
    Nochlin, D
    Walter, J
    Haass, C
    Lévesque, L
    Fraser, PE
    Andreadis, A
    Nixon, RA
    MOLECULAR MEDICINE, 2000, 6 (10) : 878 - 891